Every day we are guided by our purpose to use the power of leading-edge science to save and improve lives around the world

Read our stories…

MSD to acquire Verona Pharma

In a strategic move that strengthens our innovative pipeline of cardio-pulmonary treatments, MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) today announced it has entered into a definitive agreement to acquire, through a subsidiary, Verona Pharma, a UK-based biopharmaceutical company specialising in respiratory diseases. Under the terms of the agreement, MSD will acquire Verona Pharma for $107 […]

Innovation

Pioneering Sustainable Science: A Breakthrough in Green Chemistry

Sustainable science is taking a bold step forward in our labs at the Crick, thanks to the recent work of researchers Olivia Boyd, Mollie Hooker and their dedicated team. Their groundbreaking achievement in green chemistry showcases the innovative use of High Throughput Experimentation (HTE) and biocatalysis to optimise chemical reactions, setting new standards in our […]

Innovation

Counting the Cost: The Hidden Burden of Late Pulmonary Arterial Hypertension Diagnosis

How the implementation of a breathlessness pathway can potentially deliver benefits for our health system, and for the patients we serve. MSD in the UK have developed the infographic, Counting the Cost: The Hidden Burden of Late Pulmonary Arterial Hypertension Diagnosis, to visualise the potential impact a late diagnosis of pulmonary arterial hypertension (PAH) – […]

Partnerships

Achieving Cervical Cancer Elimination in England: Sharing Learnings, Inspiring Change

In 2023, MSD launched the Race to Elimination campaign to showcase local areas on the road to cervical cancer elimination and inspire country-wide action. Now, taking stock of the local good practice uncovered through our ‘micro-elimination roadshow’, we’re sharing learnings to accelerate action towards elimination. What is the opportunity? An estimated 850 cervical cancer deaths every […]